Efficacy of pharmacotherapy for OSA in adults: A systematic review and network meta-analysis.
Drug
Meta-analysis
Obstructive sleep apnoea
Pharmacotherapy
Randomised controlled trial
Journal
Sleep medicine reviews
ISSN: 1532-2955
Titre abrégé: Sleep Med Rev
Pays: England
ID NLM: 9804678
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
04
03
2019
revised:
11
04
2019
accepted:
16
04
2019
pubmed:
11
5
2019
medline:
6
5
2020
entrez:
11
5
2019
Statut:
ppublish
Résumé
Pharmacotherapy represents a desirable potential therapeutic alternative for patients with obstructive sleep apnoea (OSA). We aimed to summarize evidence on the efficacy of pharmacotherapy in adults with OSA and delineate the underlying mechanisms. Seven databases were systematically screened for randomised controlled trials (RCTs) from their inception to September 2018. According to a pre-registered study protocol (PROSPERO-ID-CRD42018086446) network meta-analysis was performed to obtain intervention effects on the apnoea-hypopnoea-index (AHI) based on data extracted from published reports. We identified 58 RCTs (n = 1710 patients) investigating 44 different drugs or drug-combinations. Interventions were classified into seven pathomechanism-groups and summarized narratively. A meta-analysis of 17 trials for seven drugs (acetazolamide, donepezil, mirtazapine, ondansetron, paroxetine, protriptyline, theophylline) indicated a small effect for acetazolamide (mean difference in AHI -9.6/h [-17.7; -1.4]; p = 0.02). In the network meta-analysis (I
Identifiants
pubmed: 31075665
pii: S1087-0792(19)30050-4
doi: 10.1016/j.smrv.2019.04.009
pii:
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
74-86Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.